While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

Johnson & Johnson announces positive results from phase 3b APEX study of Tremfya to treat adults living with active psoriatic arthritis: Spring House, Pennsylvania Monday, April 7 ...

The following is a summary of “Advancement and independent validation of a deep learning-based tool for automated scoring of ...

(1:09) Melissa Piliang, MD, of Cleveland Clinic, discusses comorbid chronic kidney disease in patients with psoriasis and psoriatic arthritis. (1:42) ...

[1] STEQEYMA is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult and pediatric patients, as well as Crohn's disease (CD) and ulcerative colitis (UC ...

Oruka Therapeutics, Inc.’s ORKA share price has dipped by 12.22%, which has investors questioning if this is right time to buy.

STEQEYMA is available in both subcutaneous injection and intravenous infusion and is indicated for the treatment of plaque psoriasis (PsO) and psoriatic arthritis (PsA) in adult and pediatric patients ...

Recent research captures more evidence on the psoriasis–type 2 diabetes link and attempts to pinpoint the possible genetic and pathophysiologic mechanisms underlying this connection. This study ...